3Qs: ‘Leaping’ Into The Realm of Science

By Casey Bayer Murray Gibson (center), dean of the College of Science, says that without a leap day every fourth year, summer would drift out of sync about one month every 100 years or so. Today is Feb. 29, the

3Qs: Analyzing Why Sudden Drug Shortages Occur

By Matt Colette Graham Jones, chair of the chemistry and chemical biology department, says tough FDA standards and slim profit margins for certain pharmaceuticals mean drug shortages are likely, and the global market may worsen the problem. Photo by Mary

Packing A ‘Super’ Punch

By Greg St. Martin Northeastern hosted a lecture on Sunday on the physics of superheroes’ powers ahead of the American Physical Society’s annual meeting in Boston. Over the years, superhero stories have delighted millions of fans through movies, television shows

3Qs: Analyzing ‘Linsanity’

By Jason Kornwitz Two weeks ago, boxer Floyd Mayweather Jr. caused a stir by tweeting, “Jeremy Lin is a good player, but all the hype is because he’s Asian…” How much of the attention surrounding Lin stems from the fact

A Pioneering Partnership To Cure Cystic Fibrosis

by Matt Collette Northeastern University and the Flatley Discovery Lab, a Boston-based independent, nonprofit organization, are collaborating to develop a cure for cystic fibrosis, a devastating genetic disease often overlooked by major pharmaceutical companies. Cystic fibrosis (CF) is caused by

The Scales of Human Morality

by Angela Herring “In reality, we rationalize. We deny, or we couldn’t go on living,” says Judah Rosenthal, the successful ophthalmologist whose perfect life begins to unravel in Woody Allen’s 1989 film, “Crimes and Misdemeanors.” In order to go on

FDA Releases Draft Guidelines For Biosimilar Approval Pathway

Northeastern University Provides Input on Regulatory Standards The FDA recently released draft guidelines for the Biosimilar Approval Pathway, which will accelerate the approval process for biosimilars—the generic versions of biopharmaceuticals. These guidelines will give drug companies who are producing these

Laser Show — For A Cure

by Angela Herring The naturally occurring antibiotic Actinomycin D (ActD) was approved by the Food and Drug Administration as a chemotherapy drug in 1964 and has been widely used for nearly 50 years to treat a variety of tumor types.

How We Move: A Better Predictive Model For Human Mobility Patterns

by Angela Herring “It’s human nature to want the greatest outcome for the least amount of work,” says Filippo Simini a post-doctorate researcher in Northeastern’s Center for Complex Network Research, directed by Albert-László Barabási. Simini is quoting the American linguist

3Qs: Understanding The Potential Impact Of The H5N1 Virus

Last year, in an effort to understand the biology of H5N1, two independent research groups successfully engineered the lethal avian flu virus to be transmissible between mammals, and perhaps among humans. At the end of January, the research community, including

1 30 31 32 33 34 43